Based on these metrics and many more, HRMY holds a Value grade of A, while RGEN has a Value grade of D. HRMY sticks out from RGEN in both our Zacks Rank and Style Scores models, so value investors ...

Repligen (RGEN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in ...

Repligen Corporation (NASDAQ:RGEN), a $9.36 billion market cap leader in bioprocessing technology, has been navigating a ...

Shares of Repligen Co. (NASDAQ:RGEN – Get Free Report ... They issued a “hold” rating and a $165.00 price objective on the stock. Wolfe Research assumed coverage on shares of Repligen ...

Value investors analyze a variety of traditional, tried-and-true metrics to help find companies that they believe are undervalued at their current share price levels ... into account the stock's ...

With analyst price targets ranging from $160 ... You can also see if RGEN appears on our undervalued or overvalued stock lists. These tools provide a clearer picture of investment opportunities ...

Stocks: Real-time U.S. stock quotes reflect trades reported through ... Sources: FactSet, Tullett Prebon Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange ...

According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $185.20. Shares of NASDAQ:RGEN opened at $157.29 on Thursday.